Edition:
United Kingdom

Resverlogix Gets Positive DSMB Recommendation For Phase 3 Study Of Apabetalone


Wednesday, 27 Mar 2019 

March 27 (Reuters) - Resverlogix Corp ::RESVERLOGIX ANNOUNCES NINTH POSITIVE DATA SAFETY MONITORING BOARD RECOMMENDATION FOR PHASE 3 STUDY OF APABETALONE.RESVERLOGIX CORP - DSMB REVIEWED AVAILABLE SAFETY DATA AND COMMENTED THAT NO SAFETY CONCERNS WERE IDENTIFIED.RESVERLOGIX CORP - BETONMACE TRIAL IS CURRENTLY EXPECTED TO BE COMPLETED WITHIN FIRST HALF OF CALENDAR 2019. 

Company Quote

2.87
0.11 +3.99%
8:55pm BST